Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Cardioids- a breakthrough for cardiac diseases

A Global Map of Urban Microbiomes and antimicrobial resistance.

Facts on how the brain matures.

Cardioids- a breakthrough for cardiac diseases
  • BiotechToday
  • World

Cardioids- a breakthrough for cardiac diseases

bioxone June 2, 2021June 2, 2021

Shrestha Dutta, Amity University Kolkata

Scientists have utilized human pluripotent stem cells to develop sesame seed-sized heart organoids, called cardioids, that immediately self-coordinate into beating, heart chamber-like designs, without the requirement for trial frameworks. The researchers propose their innovation has permitted them to make probably the most sensible heart organoids to date, which may upset investigation into cardiovascular problems and congenital heart defects.

Cardioids are a significant achievement. The guiding principle for the researchers is that for an in vitro tissue to be completely physiological, it additionally needs to go through organogenesis. Scientists had the option to accomplish this utilizing the developmental principles of self-association—which makes it an astonishing discovery. 

Cardiovascular defects are the main source of fatalities all around the world and are liable for around 18 million globally. Heart diseases are additionally the most widespread kind of congenital defect. The human heart is the organ that is formed first and it’s in vitro model is difficult to form. Prior the scientists have fabricated 3D heart organoids through tissue engineering. These were helpful to measure contraction force, perform compound screens, and model primary muscle and arrhythmogenic messes.

The scientists also found that the impacts on the cardioids of cryoinjury (injury by freezing), a strategy mirroring myocardial dead tissue. They utilized a virus steel bar to freeze portions of the mini-hearts, which destroyed numerous cells at the site. Apoptosis of cells is normally seen after wounds, for example, a heart attack. The researchers also found that there is a sort of cell responsible for healing an injury named cardiac fibroblasts. These cells began to move towards the site of injury and produce proteins to repair the damage. For the first time, researchers tracked down that this injury can activate an in-vivo like aggregation of extracellular network proteins in cardioids, an early sign of both recovery and fibrotic coronary illness.

Cardioids bear inconceivable potential to resolve human congenital heart disease. As the framework is physiological and versatile, this opens gigantic opportunities for drug disclosure and regenerative medication. In general, the cardioid stage has a wide potential to investigate the integral techniques of self-association and congenital disease just as to produce future develop and complex human heart models appropriate for drug revelation and regenerative medication.

Also read:A Global Map of Urban Microbiomes and antimicrobial resistance.

Source: https://healthcare-in-europe.com/en/news/cardioids-hold-great-promise-for-heart-disease-research.html

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged cardioids cardiovascular disease breakthrough cardiovascular disease treatment heart cardioid

One thought on “Cardioids- a breakthrough for cardiac diseases”

  1. Pingback: Facts on how the brain matures. - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Facts on how the brain matures.

bioxone June 2, 2021

Saptaparna Pal, Amity University Kolkata Some researchers from The Virginia School of Medicine have shed new light on how our brains mature; disclosing that the very last step in cell proliferation is important for the brain to reach its actual size and function. The new findings that are published in The Journal of Neuroscience identify […]

brain

Related Post

  • BiotechToday
  • World

STRAUMA activation: Evaluation of stroke and trauma simultaneously

BioTech Today November 9, 2021November 9, 2021

Ananya Ghosal, MAKAUT(WB) STRAUMA is an advanced hospital vigilance that permits the patient having stroke symptoms to diagnose rapidly for traumatic injuries without holding up the time for life-saving treatment and imaging of the brain. Mostly the major cause of death in the US is stroke. The common symptoms of a stroke are- Sudden confusion […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Easy-Prime – A genome editing program

bioxone August 22, 2021August 22, 2021

Madhavi Bhatia, National Pharmaceutical Education and Research, Guwahati Genome-editing technologies have made genetic studies transform from traditional interventions to precise manipulations of the DNA sequences thus resulting in both simplicity and robust outcomes. There are various genome-editing technologies, the clustered regularly interspaced short palindromic repeats (CRISPR) systems are widely used. The standard CRISPR-Cas9 method introduces […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Is the new case of the Monkeypox virus worth concerning?

BioTech Today July 20, 2021July 19, 2021

Aqsa, Jamia Millia Islamia Years after the 2003 United States outbreak of the Monkeypox virus, a new case has been reported recently. The infected person is a Texas resident who recently traveled from Africa. This patient took two flights during their return from Africa to the U.S. in early July, according to a CDC (Centre […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy